Health

Lowell Farms to Announce Third Quarter 2024 Financial and Operational Results

SALINAS, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Lowell Farms Inc. (CSE:LOWL; OTCQX:LOWLF), a California-born cannabis company with advanced production capabilities…

2 weeks ago

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

Bagsværd, Denmark, 7 November 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares…

2 weeks ago

Ipsen – October 2024 – Monthly information relative to the total number of voting rights and shares composing the share capital

Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article…

2 weeks ago

Safe out of receivership

Safe out of receivership Fleurieux-sur-l’Arbresle - France - November 6, 2024, 6.00 p.m. Safe SA and its subsidiaries announce that they…

2 weeks ago

Ramsay Sante : Q1 results as of September 30, 2024

PRESS RELEASE PRESS RELEASE                 Paris, 7th November 2024 Q1 results as of September 30, 2024 Unaudited group revenue increased by…

2 weeks ago

Avid Bioservices to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion Transaction

TUSTIN, Calif. and LONDON and BOSTON, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the…

2 weeks ago

Appili Therapeutics Announces Results of Special Meeting of Shareholders

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES HALIFAX, Nova Scotia, Nov. 06,…

2 weeks ago

SAB BIO Announces Third Quarter 2024 Financial Results and Provides Company Update

Company announced completed Phase 1 enrollment for SAB-142 with no observation of serum sickness. The company remains on track for…

2 weeks ago

Precipio Announces Q3-2024 Shareholder Update Call

Conference Call to be held on November 18, 2024, at 5:00 PM EST NEW HAVEN, Conn., Nov. 06, 2024 (GLOBE…

2 weeks ago

Praxis Precision Medicines to Participate in Three Upcoming November Investor Conferences

BOSTON, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights…

2 weeks ago